Effect of hyaluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells

Am J Nephrol. 2004 May-Jun;24(3):316-21. doi: 10.1159/000078463. Epub 2004 May 12.

Abstract

Background: Addition of hyaluronan (HA) to the dialysis solution has been suggested as a means to protect the peritoneum from injury during peritoneal dialysis (PD).

Methods: Concentrations of inflammatory mediators were determined in dialysate samples obtained from PD patients after 6-hour dwells with glucose-based (13.6 g/l) solution containing 0.1 and 0.5 g/l of exogenous high-molecular-weight HA. We additionally evaluated the effect of HA-supplemented dialysate, drained after dwell in PD patients, on function of human peritoneal mesothelial cells (MC) in in vitro culture.

Results: Concentration of nitrites was significantly higher in HA 0.5 g/l supplemented dialysate (+43%, p < 0.05) as compared to control. Levels of monocyte chemoattractant protein (MCP-1), soluble intercellular adhesive molecule (s-ICAM), vascular endothelial growth factor (VEGF) and fibronectin were comparable in all the studied groups. However, when MC were exposed in in vitro conditions for 24 h to the studied dialysates, we observed that HA containing fluids inhibited the synthesis of MCP-1, s-ICAM, VEGF and fibronectin in these cells. HA-supplemented dialysate accelerated growth rate of in vitro proliferating MC.

Conclusion: High-molecular-weight HA added to the dialysis fluid exerts anti-inflammatory and antifibrotic actions on the in vitro cultured MC and accelerates their growth rate what may be important for peritoneal healing during PD.

MeSH terms

  • Cells, Cultured
  • Dialysis Solutions / pharmacology*
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism*
  • Humans
  • Hyaluronic Acid / pharmacology*
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Peritoneum / cytology*
  • Peritoneum / drug effects
  • Peritoneum / metabolism*

Substances

  • Dialysis Solutions
  • Hyaluronic Acid